We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
+26.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.68T
AUM Growth
+$637B
(+16%)
Cap. Flow
+$33.9B
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
32.56%
Holding
4,163
New
102
Increased
2,573
Reduced
1,196
Closed
71
Avg Time Held
1
quarter
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$4.57B |
| 2 |
SPCX
SpaceX
SPCX
|
+$4.51B |
| 3 |
Marvell Technology
MRVL
|
+$3.77B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.69B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.59B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.69B |
| 3 |
Salesforce
CRM
|
+$1.28B |
| 4 |
JPMorgan Chase
JPM
|
+$1.15B |
| 5 |
HOLX
Hologic
HOLX
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Financials | 12.19% |
| 3 | Industrials | 9.6% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3976
Alaunos Therapeutics
TCRT
$2.21M
| $31.8K | ﹤0.01% |
14,063
| – | – |
2026 Q1
1 quarter
|
|
3977
OLB
OLB
$4.56M
| $31.6K | ﹤0.01% |
82,849
+75,099
| +969% | +$34.4K |
2026 Q1
1 quarter
|
|
3978
Ainos
AIMD
$10M
| $31.1K | ﹤0.01% |
16,024
+6,743
| +73% | +$12.4K |
2026 Q1
1 quarter
|
|
3979
Treasure Global
TGL
$2.42M
| $31K | ﹤0.01% |
7,948
+4,532
| +133% | +$18.9K |
2026 Q1
1 quarter
|
|
3980
DNA X Inc
SONM
$5.94M
| $30.2K | ﹤0.01% |
5,901
+1,009
| +21% | +$4.48K |
2026 Q1
1 quarter
|
|
3981
Creative Medical Technology
CELZ
$7.1M
| $29.5K | ﹤0.01% |
20,350
| – | – |
2026 Q1
1 quarter
|
|
3982
Ascendis Pharma A/S
ASND
$15B
| $29.3K | ﹤0.01% |
+110
| New | +$25.7K |
2026 Q2
0 quarters
|
|
|
MKZR
3983
MacKenzie Realty Capital
MKZR
$3.69M
| $29K | ﹤0.01% |
16,975
| – | – |
2026 Q1
1 quarter
|
|
|
DCOY
3984
Decoy Therapeutics
DCOY
$1.09M
| $29K | ﹤0.01% |
+4,034
| New | +$24.8K |
2026 Q2
0 quarters
|
|
3985
Rogers Communications
RCI
$16.8B
| $28.7K | ﹤0.01% |
+883
| New | +$31.9K |
2026 Q2
0 quarters
|
|
3986
Data Storage Corp
DTST
$7.78M
| $28.2K | ﹤0.01% |
8,165
-23,118
| -74% | -$88K |
2026 Q1
1 quarter
|
|
3987
Beyond Air
XAIR
$2.84M
| $28K | ﹤0.01% |
3,137
+1,540
| +96% | +$15.5K |
2026 Q1
1 quarter
|
|
3988
Socket Mobile
SCKT
$5.88M
| $27.8K | ﹤0.01% |
46,130
| – | – |
2026 Q1
1 quarter
|
|
3989
Vivos Therapeutics
VVOS
$3.08M
| $27.6K | ﹤0.01% |
60,629
-212,700
| -78% | -$167K |
2026 Q1
1 quarter
|
|
|
MWYN
3990
Marwynn Holdings
MWYN
$21.6M
| $27.4K | ﹤0.01% |
+25,853
| New | +$21.3K |
2026 Q2
0 quarters
|
|
|
JUNS
3991
Jupiter Neurosciences
JUNS
$3.43M
| $27.4K | ﹤0.01% |
1,707
-3,092
| -64% | -$73.1K |
2026 Q1
1 quarter
|
|
|
FOXX
3992
Foxx Development Holdings
FOXX
$18.4M
| $27.2K | ﹤0.01% |
8,313
| – | – |
2026 Q1
1 quarter
|
|
3993
Bolt Biotherapeutics
BOLT
$6.74M
| $27.2K | ﹤0.01% |
7,060
| – | – |
2026 Q1
1 quarter
|
|
3994
Avalon Holdings
AWX
$9.75M
| $26.5K | ﹤0.01% |
10,649
| – | – |
2026 Q1
1 quarter
|
|
3995
FibroBiologics
FBLG
$8M
| $26.3K | ﹤0.01% |
27,769
-39,896
| -59% | -$46.3K |
2026 Q1
1 quarter
|
|
3996
Yunhong Green CTI Ltd
YHGJ
$7.28M
| $26.2K | ﹤0.01% |
8,707
| – | – |
2026 Q1
1 quarter
|
|
3997
Biomerica
BMRA
$9.84M
| $25.5K | ﹤0.01% |
14,514
| – | – |
2026 Q1
1 quarter
|
|
|
ESYN
3998
EnerSyn Global Inc. Common Stock
ESYN
$17M
| $25.2K | ﹤0.01% |
17,751
| – | – |
2026 Q1
1 quarter
|
|
3999
AquaBounty Technologies
AQB
$4.81M
| $25K | ﹤0.01% |
23,371
| – | – |
2026 Q1
1 quarter
|
|
|
VSEE
4000
DELISTED
VSEE HEALTH INC
VSEE
| $24.8K | ﹤0.01% |
213,716
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.2%. Vanguard Capital Management opened 102 new positions and exited 71, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
- Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
- Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
- Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
- Vanguard Capital Management opened 102 new positions and closed 71 in Q2 2026.
- Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.